Myoform Launches Personalized Supplements That Redefine Athletic Performance Through Genomics

NATIONWIDE - APRIL 2025 - (USAnews.com) - Myoform, a London-based health technology startup co-founded by Theo Wiley and Sacha Attiach, is pioneering a new standard in proactive wellness by introducing a personalized supplement solution tailored to each individual’s genetic profile and health goals. With a mission to transition healthcare from reactive treatment to data-driven prevention, Myoform applies the principles of precision medicine—traditionally used in disease management—to the realm of nutrition and athletic performance.

Rooted in personal experience and scientific inquiry, Co-Founder and CEO Theo Wiley developed the Myoform concept after facing challenges with unregulated supplements and managing a genetic form of hearing loss. These experiences underscored the limitations of one-size-fits-all health solutions and inspired a vision for safe, individualized products. As Wiley explains, “In 5 years, no one will take a generic multivitamin or performance supplement. Precision health is where it’s all heading—and we’re building that future now.”

Myoform’s process begins with a home-delivered saliva collection kit that enables whole genome sequencing (WGS)—a method that maps all 3 billion base pairs of the customer’s DNA. This comprehensive approach sets Myoform apart from traditional direct-to-consumer genetic tests that typically examine only a fraction of the genome. In tandem with a detailed lifestyle and health questionnaire, this data is processed through Myoform’s proprietary personalization engine, which uses polygenic risk scoring and machine learning to deliver a truly customized supplement formulation.

These formulations are produced in powder form, eliminating the need for multiple pills and allowing for clinically dosed ingredients in a single blend. Supplements are delivered via subscription in three-month batches, manufactured entirely in-house under rigorous quality control standards. Ingredients are independently tested and certified drug-free through Informed Sport and NSF, ensuring safety and transparency for professional athletes and health-conscious users alike.

The company’s initial focus has been on high-performance individuals, including professional and amateur athletes seeking optimized recovery, endurance, and strength. In a 12-week beta trial in 2023/24 involving 20 athletes, users reported an average performance improvement of 23.5% across seven metrics. These results have formed the foundation for ongoing validation initiatives and partnerships with sports organizations, as Myoform prepares for a broader market launch.

As Wiley explains, the long-term vision for Myoform is to bring these high-level technologies to the wider public. “Coming from the world of precision medicine and gene therapies, it occurred to me that whilst these technologies are incredible for curing disease, prevention really hadn't been cracked—so why not think about applying these approaches to health products we take every day? Much like Formula 1 racing, these incredible technologies gradually trickle their way into the cars we drive every day—we're just doing that with Myoform, except instead of cars, it’s our human 'engines'.”

Myoform’s personalization engine incorporates a continuously updated database of over 1,000 peer-reviewed studies. The platform not only assesses genetic predispositions—such as nutrient metabolism and injury risk—but also factors in evolving health metrics. In future iterations, Myoform intends to integrate blood biomarker testing to further refine recommendations based on real-time physiological changes.

In addition to product innovation, the company is actively pursuing a patent in the UK, EU, and US to protect its core system, which combines biological sampling with survey data in a feedback-driven model to optimize supplement efficacy. This patent serves as both a barrier to entry for competitors and a foundational asset in Myoform’s broader commercialization strategy.

The competitive landscape in personalized nutrition includes firms such as Stride, Vitl, and NGX, but Myoform distinguishes itself through its comprehensive testing, performance-specific focus, and dynamic data integration. Unlike others who rely solely on surveys or static genomic snapshots, Myoform’s model allows for continuous optimization and greater depth of personalization. Moreover, unlike generic brands such as MyProtein or Huel, Myoform targets serious athletes with custom formulations designed for measurable outcomes.

Myoform’s co-founders bring complementary expertise to the company’s technological and scientific base. Wiley, a human bioscientist with experience across SaaS, biotechnology, and healthcare, oversees business strategy and public engagement. Attiach, Myoform’s Chief Technology Officer, combines neuroscience and software engineering experience to lead the development of the genomics engine and digital platform.

From its early association with the University of Exeter’s SETsquared incubator to coverage by industry outlets like Health Tech World and PreSeed Now, Myoform has steadily gained visibility as a rising innovator in the nutraceutical and sports science arenas. Wiley has also appeared at the NutraIngredients Active Nutrition Summit to share insights on the role of automation and accessibility in precision health.

Looking ahead, Myoform plans to scale operations through automation and strategic partnerships with multiple professional sports teams, enabling a more accessible path to personalized nutrition. The company is currently concluding its invite-only pre-launch phase, is planning a formal clinical trial to initiate mid-2025, and is expected to debut its full service to the public in late 2025. Early traction with athletes, successful pilot data, and industry recognition suggest that Myoform is well-positioned to redefine the supplement market through a science-first, individualized approach.

For more information, visit Myoform.io, follow on Instagram, or connect via LinkedIn. Reviews and testimonials can be found on Trustpilot.